Virology Research Today is a free monthly online journal that collates and summarizes the latest research about Virology, including details on viruses, pathology, classification, definitions.

Volume 2 (2006), Issue 1 (January)

1. Clinical and virological effects during two years of ongoing adefovir dipivoxil in the treatment of lamivudine-resistant chronic hepatitis B infection.
   Transplant Proc, 37(9): 3957-9. [Abstract] [Full-text]
2. Virological, serological, and clinical features of an outbreak of acute gastroenteritis due to recombinant genogroup II norovirus in an infant home.
   J Clin Microbiol, 44(1): 177-82. [Abstract] [Full-text]
3. Cyclosporine suppresses hepatitis C virus in vitro and increases the chance of a sustained virological response after liver transplantation.
   Liver Transpl, 12(1): 51-7. [Abstract] [Full-text]
4. A virologic survey of patients admitted to a critical care unit for acute cardiorespiratory failure.
   Intensive Care Med, 32(1): 156-9. [Abstract] [Full-text]
5. Prevalence of hepatitis C virus infection and HCV genotypes among hemophiliacs in the State of Bahia, Northeastern Brazil: analysis of serological and virological parameters.
   Rev Soc Bras Med Trop, 38(6): 496-502. [Abstract] [Full-text]
6. Virological, serological and epidemiological study of 255 consecutive cases of genital herpes in a sexually transmitted disease clinic of Paris (France): a prospective study.
   Int J STD AIDS, 17(1): 44-9. [Abstract] [Full-text]
7. HCV virological assessment.
   J Hepatol, 44(1): S35-9. [Abstract] [Full-text]
8. HBV virological assessment.
   J Hepatol, 44(1): S71-6. [Abstract] [Full-text]
9. Virology of hepatitis B and C viruses and antiviral targets.
   J Hepatol, 44(1): S10-3. [Abstract] [Full-text]
10. Virological analysis and phenotypic characterization of peripheral blood lymphocytes of hepatitis C virus-infected patients with and without mixed cryoglobulinaemia.
    Clin Exp Immunol, 143(2): 288-96. [Abstract] [Full-text]
11. Virologic response and resistance to adefovir in patients with chronic hepatitis B.
    J Hepatol, 44(2): 283-90. [Abstract] [Full-text]
12. Immunological and virological responses to highly active antiretroviral therapy in a non-clinical trial setting in a developing Caribbean country.
    HIV Med, 7(2): 99-104. [Abstract] [Full-text]
13. Pathogenesis of experimental encephalomyocarditis: a histopathological, immunohistochemical and virological study in rats.
    J Comp Pathol, 134(1): 30-9. [Abstract] [Full-text]
14. Long-term adherence to first-line highly active antiretroviral therapy in a hospital-based cohort: predictors and impact on virologic response and relapse.
    AIDS Patient Care STDS, 20(1): 48-56. [Abstract] [Full-text]
15. Dose-dependent and genotype-independent sustained virological response of a 12 week pegylated interferon alpha-2b treatment for acute hepatitis C.
    J Antimicrob Chemother, 57(2): 360-3. [Abstract] [Full-text]
16. Clinical and virological features of non-breakthrough and severe exacerbation due to lamivudine-resistant hepatitis B virus mutants.
    J Med Virol, 78(3): 341-52. [Abstract] [Full-text]
17. Long-term statin use does not act on the temporal trend of CD4 cell count in patients on virologically effective HAART.
    AIDS, 20(3): 455-7. [Abstract] [Full-text]
18. Disease progression in patients with virological suppression in response to HAART is associated with the degree of immunological response.
    AIDS, 20(3): 371-7. [Abstract] [Full-text]
19. Long-term follow-up of chronic hepatitis C patients with sustained virological response to various forms of interferon-based anti-viral therapy.
    Aliment Pharmacol Ther, 23(4): 507-11. [Abstract] [Full-text]

© 2005-2008 Virology Research Today. All Rights Reserved.